Multi-resistant tuberculosis at the hôpital d'instruction des armées de Libreville (Gabon) about 16 cases;Tuberculose multirésistante àl'hôpital d'instruction des armées de Libreville (Gabon) àpropos de 16 cas

Bulletin de la Societe de Pathologie Exotique

Volumn 105, Issue 1, 2012, Pages 1-4

  Mounguengui, D ^a   Ondounda, M ^a   Mandji Lawson, J M ^a   Fabre, M ^b   Gaudong, L ^a   Mangouka, L ^a   Magne, C ^a   Nzenze, J R ^a   L'Her, P ^b  

^a Hôpital D'instruction des Armées OBO   (Gabon)

^b PERCY MILITARY HOSPITAL   (France)

Author keywords

Diagnosis; Gabon; MDR; Multi drug resist tuberculosis; Sub Saharan Africa; Treatment

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLASSIFICATION; COHORT ANALYSIS; FEMALE; GABON; HUMAN; MALE; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; PUBLIC HOSPITAL; STATISTICS;

ADULT; ANTITUBERCULAR AGENTS; COHORT STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GABON; HOSPITALS, MILITARY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84856649952     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13149-011-0195-8     Document Type: Article

References (28)

1. Ahmad S, Mokaddas E (2009) Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respir Med 103 (12):1777-90 [Epub 2009 Aug 5]
2. Andrews JR, Shah NS, Gandhi N, et al (2007) Multidrugresistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. J Infect Dis 196(S3):482-90
3. Benfenatki N (2009) La tuberculose multirésistante. Rev Med Interne 30S:268-72
4. Bercion R, Kuaban C (1998) Résistance de Mycobatrium tuberculosis complexe aux principaux antibacillaires àYaoundé, Cameroun. Bull Soc Pathol Exot 91(3):199-202 [http://www.pathexo.fr/documents/articles-bull/ T91-3-1860.pdf] (Pubitemid 128375741)
5. Blanc FX (2006) Tuberculose : encore plus fort que la multirésistance. Rev Mal Respir 23(15):86-8
6. Haltiti R, Zarrouk M, Merdassi H, et al (2007) La tuberculose multirésistante du sujet immunocompétent dans la région du Nord-Est de la Tunisie : àpropos de 43 cas. Rev Mal Respir 24 (HS1):113
7. James P, Gupta R, Christopher DJ, et al (2011) MDR- and XDRTB among suspected drug-resistant TB patients in a tertiary care hospital in India. Clin Respir J 5(1):19-25
8. Johnson R, Jordan AM, Pretorius L, et al (2006) Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Dis 10(1):68-73 (Pubitemid 43266280)
9. Johnson R, Streicher EM, Louw GE, et al (2006) Drug resistance in Mycobactrium tuberculosis. Curr Issues Mol Biol 8(2):97-111
10. Kabedi MJ, Kashongwe M, Kayembe JM, et al (2007) Résistance primaire de Mycobacterium tuberculosis aux antituberculeux àKinshasa, République démocratique du Congo. Bull Soc Pathol Exot 100(4):275-6 [http://www.pathexo.fr/documents/articlesbull/T100-4-3022-2p.pdf]
11. Koeck JL, Bernatas JJ, Gerome P, et al (2002) Épidémiologie de la résistance aux antituberculeux des souches du complexe Mycobacterium tuberculosis isolées d'adénopathies àDjibouti. Étude prospective réalisée en 1999. Med Trop 62(1):70-2
12. Kvasnovsky CL, Cegielski JP, Erasmus R, et al (2011) Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients. J Acquir Immune Defic Syndr 57(2):146-52
13. Louw GE, Warren RM, Donnald PR, et al (2006) Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis 10(7):802-7 (Pubitemid 44031396)
14. Lumb R, Bastion I, Carter R, et al (2009) Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2007. A report of the Australian Mycobacterium Reference Laboratory Network. Commun Dis Intell 33(3):298-303
15. Migliori GB, D'Arcy Richardson M, Sotgiu G, Lange C (2009) Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control. Clin Chest Med 30(4):637-65
16. Nech MA, Ould Abdoullah Sejad MM, Toloba Y (2009) La tuberculose pulmonaire multirésistante : àpropos de 60 cas. Rev Mal Respir 26(HS1):137
17. Olusoji D, Eltayeb O (2011) Prevalence and risk factors associated with drug resistant TB in South West, Nigeria. Asian Pac J Trop Med 4(2):148-51
18. OMS (2007) La tuberculose multirésistante et ultraré sistante. EUR/TB/FS03
19. OMS (2008) Anti-tuberculosis drug resistance in the World. Fourth Global Report
20. OMS (2009) Tuberculose multirésistante et ultrarésistante : prévention et lutte
21. OMS (2009) Stratégie de coopération de l'OMS avec les pays 2008-2013. Gabon [http://www.who.int/countries/gab/fr]
22. OMS (2011) Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015. Progress report 2011
23. Ouédraogo M, Ouédraogo SM, Coulibaly YG, et al (1999) Tuberculose àbacilles multirésistants en zone de forte prévalence : àpropos de huit cas. Med Afr Noire 46(8/9)
24. Samo Gudo P, Cuna Z, Coelho E, et al (2011) Is multidrugresistant tuberculosis on the rise in Mozambique? Results of a national drug resistance survey. Eur Respir J 38(1):222-4
25. Sánchez-Pérez HJ, Díaz-Vázquez A, Nájera-Ortiz JC, et al (2010) Multidrug-resistant pulmonary tuberculosis in Los Altos, Selva and Norte regions, Chiapas, Mexico. Int J Tuberc Lung Dis 14 (1):34-9
26. Schaaf HS, Moll AP, Dheda K (2009) Multidrug- and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children. Clin Chest Med 30(4)667-83
27. Tang S, Zhang Q, Yu J, et al (2011) Extensively drug-resistant tuberculosis, China. Emerg Infect Dis 17(3):558-60
28. Vashakidze L, Salakaia A, Shubladze N, et al (2009) Prevalence and risk factors for drug resistance among hospitalized tuberculosis patients in Georgia. Int J Tuberc Lung Dis 13(9):1148-53